Amneal launches generic Ery-Tab
Amneal is introducing erythromycin delayed-release tablets.
It is the first generic of Arbor Pharmaceuticals’ Ery-Tab.
Erythromycin delayed-release tablets are indicated in the treatment of infections caused by susceptible strains of designated microorganisms in a variety of diseases.
It comes in 500 mg, 333 mg, and 250 mg dosage strengths.
It is the first generic of Arbor Pharmaceuticals’ Ery-Tab.
Erythromycin delayed-release tablets are indicated in the treatment of infections caused by susceptible strains of designated microorganisms in a variety of diseases.
It comes in 500 mg, 333 mg, and 250 mg dosage strengths.